GR3021382T3 - Human lymphoid tissue in an immunocompromised host - Google Patents

Human lymphoid tissue in an immunocompromised host

Info

Publication number
GR3021382T3
GR3021382T3 GR960402755T GR960402755T GR3021382T3 GR 3021382 T3 GR3021382 T3 GR 3021382T3 GR 960402755 T GR960402755 T GR 960402755T GR 960402755 T GR960402755 T GR 960402755T GR 3021382 T3 GR3021382 T3 GR 3021382T3
Authority
GR
Greece
Prior art keywords
lymphoid tissue
immunocompromised host
human
human lymphoid
tissue
Prior art date
Application number
GR960402755T
Other languages
English (en)
Inventor
Susan Mayo
Reiko Namikawa
Hideto Kaneshima
Joseph M Mccune
Original Assignee
Systemix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Systemix Inc filed Critical Systemix Inc
Publication of GR3021382T3 publication Critical patent/GR3021382T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Surgical Instruments (AREA)
  • Peptides Or Proteins (AREA)
GR960402755T 1990-05-03 1996-10-16 Human lymphoid tissue in an immunocompromised host GR3021382T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51874890A 1990-05-03 1990-05-03
PCT/US1991/002938 WO1991016910A1 (en) 1990-05-03 1991-04-29 Human lymphoid tissue in an immunocompromised host

Publications (1)

Publication Number Publication Date
GR3021382T3 true GR3021382T3 (en) 1997-01-31

Family

ID=24065324

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402755T GR3021382T3 (en) 1990-05-03 1996-10-16 Human lymphoid tissue in an immunocompromised host

Country Status (11)

Country Link
US (1) US5411749A (el)
EP (1) EP0481058B1 (el)
JP (1) JPH04507109A (el)
AT (1) ATE140480T1 (el)
AU (1) AU637914B2 (el)
CA (1) CA2063408A1 (el)
DE (1) DE69120890T2 (el)
DK (1) DK0481058T3 (el)
ES (1) ES2090332T3 (el)
GR (1) GR3021382T3 (el)
WO (1) WO1991016910A1 (el)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5849288A (en) * 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
DK9091D0 (da) * 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
US5804160A (en) * 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
US5858328A (en) * 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5849987A (en) * 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
DE69229254T2 (de) * 1991-10-30 1999-09-23 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
US5866757A (en) * 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
WO1994006283A1 (en) * 1992-09-11 1994-03-31 The Regents Of The University Of Michigan Non-human animal with xenograft of on airway populated by human cells
US5663481A (en) * 1993-08-06 1997-09-02 Mount Sinai Hospital Corporation Animal model of the human immune system
US5645982A (en) * 1993-08-19 1997-07-08 Systemix, Inc. Method for screening potential therapeutically effective antiviral agents
US5516977A (en) * 1993-12-17 1996-05-14 Systemix, Inc. Xenogeneic tissue implant in ear pinna
US6455756B1 (en) * 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
CA2205138A1 (en) * 1994-11-16 1996-05-23 Baxter International Inc. Human antibodies to t-cell receptor peptides and methods for their preparation
US5811524A (en) 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US5986170A (en) * 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
EP0973381B1 (en) * 1997-04-09 2010-03-03 AMDL, Inc. Animal model for evaluation of vaccines
CA2398466A1 (en) * 2000-01-27 2001-08-02 Medimmune, Inc. Ultra high affinity neutralizing antibodies
AU4002001A (en) 2000-03-01 2001-09-12 Med Immune Inc High potency recombinant antibodies and method for producing them
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
CA2542232A1 (en) 2003-06-09 2005-01-20 Alnylam Pharmaceuticals, Inc. Method for treating neurodegenerative disease by inhibiting alpha-synuclein
US20060115485A1 (en) * 2004-10-29 2006-06-01 Medimmune, Inc. Methods of preventing and treating RSV infections and related conditions
EP1997830A1 (en) * 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
US8541646B2 (en) 2009-10-06 2013-09-24 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
US20110229921A1 (en) 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
US9551714B2 (en) 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
IN2015DN02032A (el) 2012-09-07 2015-08-14 Univ Yale
ES2884598T3 (es) 2012-11-05 2021-12-10 Regeneron Pharma Animales no humanos modificados genéticamente y métodos de uso de los mismos
PT3482629T (pt) 2014-05-19 2021-02-18 Univ Yale Animais não humanos geneticamente modificados que expressam epo humana
PT3282835T (pt) 2015-04-13 2023-07-25 Univ Yale Ratinhos knockin de sirpa-il15 humanizadas e métodos de utilização dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853201T2 (de) * 1987-12-23 1995-09-14 Univ Leland Stanford Junior Schimäre immunkompromittierende Säugetiere und ihre Verwendung.
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
DE69131331T2 (de) * 1990-01-15 2000-03-02 Yeda Research And Development Co., Ltd. Dauerhafte Verpflanzung und Entwicklung menschlicher hämatopoietischer Zellinien bei normalen Säugetieren
JPH05500617A (ja) * 1990-05-25 1993-02-12 システミックス，インコーポレイティド 免疫処理された宿主におけるヒト末梢血液細胞
JPH04252128A (ja) * 1990-08-03 1992-09-08 Systemix Inc 免疫化された宿主における変性された異種移植器官系

Also Published As

Publication number Publication date
EP0481058A4 (en) 1993-07-14
DE69120890T2 (de) 1997-02-20
WO1991016910A1 (en) 1991-11-14
JPH04507109A (ja) 1992-12-10
EP0481058B1 (en) 1996-07-17
AU637914B2 (en) 1993-06-10
EP0481058A1 (en) 1992-04-22
US5411749A (en) 1995-05-02
ATE140480T1 (de) 1996-08-15
CA2063408A1 (en) 1991-11-04
ES2090332T3 (es) 1996-10-16
DE69120890D1 (de) 1996-08-22
AU7858391A (en) 1991-11-27
DK0481058T3 (da) 1996-12-02

Similar Documents

Publication Publication Date Title
EP0481058A4 (en) Human lymphoid tissue in an immunocompromised host
EP0474727A4 (en) Her2 extracellular domain
DE68924162D1 (de) Stressproteine und verwendungen dafür.
NO933126D0 (no) Loeselige ligander for cd40
GB2277270A (en) Electrophysiological conditioning system and method
DE69329503D1 (de) Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
GR3024635T3 (en) Monoclonal antibodies directed against the microtubule-associated protein tau.
SG50681A1 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
ES2145004T3 (es) Derivados de anticuerpos.
EP0570583A4 (en) ACTIVE SUBSTANCE FOR HAIR MODIFICATION AND HAIR CARE PRODUCT, WHICH CONTAIN BOTH AN ANTI-KERATINE ANTIBODY, AND PRODUCTION OF THE ANTI-KERATINE ANTIBODY.
ATE195875T1 (de) Spezifische modulationen des immunsystems
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
WO1996022373A3 (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
SE8008415L (sv) Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-)
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
ATE138195T1 (de) Menschliches immunsystem in maus
EP0493446A4 (en) Treatment of autoimmune disease
NO870123D0 (no) Mastittvaksine.
FI913566A0 (fi) Oekad proteinproduktion i djur.
GR3021983T3 (en) Cross-reactive influenza a immunization
ES2109954T3 (es) Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento.
SU703082A1 (ru) Способ приготовлени м сных изделий
GB867920A (en) Process for the cooking of animal tissue
GB1380554A (en) Treatment of poultry
UA10052A (uk) Спосіб лікування ендометріоза